An increasing number of studies have revealed the clinical relevance of Th17/Th1 cells and IL-17A and IFN-γ in patients with immune diseases such as autoimmune diseases (43, 44) and many other intestinal immune diseases (12–15). This evidence concerns the gene IL17A and immune system disorder.